Endocrinology, Vol 109, 2252-2254, Copyright © 1981 by Endocrine Society

ARTICLES

Parathyroid hormone has a positive inotropic action in the rat

Y Katoh, KL Klein, RA Kaplan, WG Sanborn and K Kurokawa

Parathyroid hormone (PTH: synthetic bovine, amino terminus 1-34 amino acids) demonstrates a positive inotropic action on the isolated papillary muscle of the rat heart. The effect was evident at PTH concentration of 10(-12)M, and the maximum inotropic effect occurred with PTH concentrations greater than 10(-11)M. Biologically inactive PTH (PTH treated with H2O2) was without effect. The inotropic effect of PTH was partially blocked by propranolol and also suppressed in the papillary muscle of the rat pretreated with reserpine. Methoxyverapamil completely blocked the inotropic action of PTH. PTH was without effects on adenylate cyclase activity of the myocardium. Results show the presence of an inotropic action of PTH in vitro and suggest that this action of PTH is partially mediated by releasing the endogenous myocardial norepinephrine which exerts a positive inotropic effect via beta-adrenergic stimulation and by an increase in Ca++ influx across plasma membranes, but independent of adenylate cyclase activation. The inotropic action of PTH may be of significance in normal cardiac function.

This article has been cited by other articles:

				E. Occhetta, M. Bortnik, A. Magnani, G. Francalacci, and C. Vassanelli Primary hyperparathyroidism and arrhythmic storm in a patient with an implantable cardioverter defibrillator for primary prevention of sudden death Europace, January 1, 2004; 6(3): 184 - 188. [Abstract] [Full Text] [PDF]

				F.N Saleh, H Schirmer, J Sundsfjord, and R Jorde Parathyroid hormone and left ventricular hypertrophy Eur. Heart J., November 2, 2003; 24(22): 2054 - 2060. [Abstract] [Full Text] [PDF]

				S. Yamamoto, I. Morimoto, Y. Tanaka, N. Yanagihara, and S. Eto The Mutual Regulation of Arginine-Vasopressin and PTHrP Secretion in Dissociated Supraoptic Neurons Endocrinology, April 1, 2002; 143(4): 1521 - 1529. [Abstract] [Full Text] [PDF]

				S. J. Marchais, F. Metivier, A. P. Guerin, and G. M. London Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2178 - 2183. [Abstract] [Full Text] [PDF]

				S. Yamamoto, I. Morimoto, K. Zeki, Y. Ueta, H. Yamashita, H. Kannan, and S. Eto Centrally Administered Parathyroid Hormone (PTH)-Related Protein(1-34) But Not PTH(1-34) Stimulates Arginine-Vasopressin Secretion and Its Messenger Ribonucleic Acid Expression in Supraoptic Nucleus of the Conscious Rats Endocrinology, January 1, 1998; 139(1): 383 - 388. [Abstract] [Full Text] [PDF]

				K.-D. Schluter and H. M. Piper Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide Cardiovasc Res, January 1, 1998; 37(1): 34 - 41. [Abstract] [Full Text] [PDF]

				S. Yamamoto, I. Morimoto, N. Yanagihara, K. Zeki, T. Fujihira, F. Izumi, H. Yamashita, and S. Eto Parathyroid Hormone-Related Peptide-(1-34) [PTHrP- (1-34)] Induces Vasopressin Release from the Rat Supraoptic Nucleus in Vitro through a Novel Receptor Distinct from a Type I or Type II PTH/PTHrP Receptor Endocrinology, May 1, 1997; 138(5): 2066 - 2072. [Abstract] [Full Text] [PDF]